American Well Corporation (AMWL)
| Market Cap | 5.98B |
| Revenue (ttm) | 229.86M |
| Net Income (ttm) | -196.56M |
| Shares Out | 68.50M |
| EPS (ttm) | -2.87 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | February 25 |
| Last Price | $25.38 |
| Previous Close | $26.32 |
| Change ($) | -0.94 |
| Change (%) | -3.57% |
| Day's Open | 26.00 |
| Day's Range | 24.60 - 26.54 |
| Day's Volume | 2,526,570 |
| 52-Week Range | 21.34 - 43.75 |
How have these big healthcare IPOs been doing?
BOSTON--(BUSINESS WIRE)--Amwell expands technology platform with the launch of Hospital TV 100
While you can chase the latest fads on Wall Street, these stocks for beginners provide more sustainable opportunities. The post 8 Stocks to Buy for Beginners in a Hot Market appeared first on ...
Hint: Much of a company's success has to do with the experiences and diversity of its leadership.
Insider sold 5% of the company at $27.50 via a secondary offering. The vaccine rollout should make for tough telehealth visit comps this year.
Telemedicine is here to stay as the new coronavirus strain triggers a fear psychosis at large, thereby retaining solid demand for telehealth stocks.
Two are telemedicine leaders already, and one could be on its way to becoming a major player.
Investors need to pay close attention to American Well (AMWL) stock based on the movements in the options market lately.
BOSTON--(BUSINESS WIRE)--Amwell® (NYSE: AMWL), a national telehealth leader, today announced the pricing of a public offering of 11,280,647 shares of its Class A common stock by certain stockh...
BOSTON--(BUSINESS WIRE)--Amwell® (NYSE: AMWL), a national telehealth leader, today announced that it has commenced the roadshow for a proposed public offering. Amwell has filed a registration ...
BOSTON--(BUSINESS WIRE)--Amwell announces the launch of Amwell Psychiatric Care and that its psychiatric medical group has been recognized by The Joint Commission.
The two telemedicine companies are witnessing exponential sales growth. Which one is the better buy?
The U.S. market for initial public offerings (IPOs) had a banner year in 2020 despite the pandemic — or perhaps because of it. Connected-commerce companies often led the way, frequently enjoyi...
The need for touchless treatment, safety, ease, flexibility and efficiency in the current healthcare system makes telehealth a much sought-after option to provide care in the future.
AMWL stock is once again falling thanks to an announcement that Amazon is looking to move further into telehealth. Here's what to know now.
AMWL stock is plunging Tuesday without any real news from telemedicine play Amwell. Here's one potential reason for the big move.
Expect telehealth stocks to continue trending upward even though Covid-19 is slowly but surely receding into the background. The post 5 Telehealth Stocks That Will Keep Growing Post-Quarantine...
Telehealth stocks have been huge winners in 2020, thanks to the novel coronavirus pandemic. These 3 have solid cases for 2021 and beyond.
Third-quarter 2020 earnings only reinforce the massive changes taking place in the world of healthcare.
Don't count out telehealth stocks just yet. There's still plenty of demand as patients and providers become comfortable with virtual care.
Coronavirus and telehealth: CEO discusses the need for digital health care amid coronavirus
Amwell Cleveland Clinic Digital Health CEO discusses the coronavirus pandemic, the stress on hospitals as health care workers become infected with COVID-19, and the increase in telehealth amid...
Telehealth bellwether Amwell may be weighing a mental health acquisition: When asked about the possibility after its latest earnings call, CEO Ido Schoenberg told Business Insider Premium: "Y...
Shares of the telehealth platform provider have tumbled since the company's successful stock market debut in September.
CLEVELAND & BOSTON--(BUSINESS WIRE)--The Cleveland Clinic and Amwell joint venture welcomes Egbert van Acht as Executive Vice Chairman to the Board of Directors and Frank McGillin as CEO
BOSTON--(BUSINESS WIRE)--Amwell®, (NYSE: AMWL) (the "Company") a national telehealth leader, today announced that Ido Schoenberg, Chairman and Co-Chief Executive Officer and Keith Anderson, Ch...
Amwell is another high-priced telehealth stock with no profits. Avoid AMWL stock which trades at 24 times sales with no earnings prospects in the near term.
Baron Funds recently released its portfolio updates for the third quarter of 2020, which ended on Sept. 30.
After hitting a high of nearly $42 in early October on takeover speculation, shares of American Well Corp. (NYSE:AMWL) are about where they were post-initial public offering, just short of $23...
Now that a COVID-19 vaccine may be on the way, which telehealth company is best positioned for continued growth?
Telehealth stocks have come to prominence in 2020 for obvious reasons. Read on for those that are positioned to thrive moving forward.
Amwell CEO on the growing telehealth industry and the company's third quarter results
Doctor Ido Schoenberg, Amwell CEO and chairman, joins 'Squawk Alley' to discuss the disconnect between markets and the company's quarterly earnings, the future of telehealth and the risks pose...
American Well's (AMWL) CEO Ido Schoenberg on Q3 2020 Results - Earnings Call Transcript
BOSTON--(BUSINESS WIRE)--Amwell®, (NYSE: AMWL) (the "Company") a national telehealth leader, today announced financial results for the third quarter ended September 30, 2020. “We are pleased t...
BOSTON--(BUSINESS WIRE)--Amwell announces Amwell Now and an expanded Carepoint portfolio, designed to meet the needs of care teams and patients for simple telehealth access
There are no silver linings to the pandemic. Nevertheless, some stocks and sectors have benefited greatly from the societal changes COVID-19 has wrought.
As virtual visits become commonplace, investors can take a stake in the burgeoning telemedicine field with AMWL stock shares. The post Skyrocketing Telehealth Use Will Propel American Well Sto...
Although the rally from the March doldrums has skyrocketed many companies, there are still some cheap stocks to advantage. The post 9 Cheap Stocks to Buy on the Transition of Power appeared fi...
As the second wave of Covid-19 provides tailwinds for digital health care, here are three top telehealth stocks to buy in the coming weeks. The post 3 Telehealth Stocks for a Second Wave appea...
The pandemic's worsening trends favor these businesses.
Digital healthcare stocks are popular currently, but investors need to think twice about this one.
While the new normal has produced some crazy trading ideas regarding Generation Z stocks, these companies offer sound, bullish arguments for investing for the next decade. The post The 10 Best...
Both telehealth companies have seen growth accelerate during the pandemic, but your business philosophy may determine which stock is best for you.
With a second wave of Covid-19 likely to slam us, American Well stock has obvious relevance that you shouldn't be quick to ignore. The post How a Second Wave May Offer a ‘Mulligan' for America...
With several growth stocks encountering a steep discount from the coronavirus panic, many early speculators have benefitted tremendously. However, those getting in late to the game still have ...
You can accumulate American Well stock shares as telehealth will continue to be in high demand as the pandemic plays out through 2021. The post Brace for Covid 2.0 With a Stake in American Wel...
The stock has doubled since its hot IPO, but coronavirus-induced trends might not be enough to satisfy investors seeking outsized gains.
Recent IPOs have included some of the bigger winners of the past few years. But these seven stocks could hit trouble soon after going public.
About AMWL
American Well Corporation provides a telehealth application that connects and enables providers, insurers, patients, and innovators to deliver access to healthcare. Its application offers urgent care; pediatrics; therapy; menopause nutrition; menopause counseling; telestroke; population health management; telepsychiatry; pregnancy and postpartum nutrition; pregnancy and postpartum therapy; breastfeed support; menopause care; pregnancy and postpartum care; and chromic disease management services. The company also provides telemedicine equipment,... [Read more...]
| Industry Health Information Services | IPO Date Sep 17, 2020 |
| CEO Dr. Ido Schoenberg | Employees 686 |
| Stock Exchange NYSE | Ticker Symbol AMWL |
Financial Performance
In 2019, Amwell's revenue was $148.86 million, an increase of 30.63% compared to the previous year's $113.96 million. Losses were -$87.19 million, 65.5% more than in 2018.
Analyst Forecasts
According to 9 analysts, the average rating for Amwell stock is "Buy." The 12-month stock price forecast is 35.11, which is an increase of 38.34% from the latest price.